Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Frazier TG, Fox KR, Smith JS, Laronga C, McSwain A, Paul D, Schultz M, Stilwill J, Teal C, Weisberg T, Vacchino JF, Sing AP, Cherepanov D, Hsiao W, Chang E, Broder MS. Frazier TG, et al. Among authors: laronga c. Pharmaceuticals (Basel). 2015 Mar 17;8(1):107-22. doi: 10.3390/ph8010107. Pharmaceuticals (Basel). 2015. PMID: 25789420 Free PMC article.
Gene expression profiling in breast cancer.
Turaga K, Acs G, Laronga C. Turaga K, et al. Among authors: laronga c. Cancer Control. 2010 Jul;17(3):177-82. doi: 10.1177/107327481001700306. Cancer Control. 2010. PMID: 20664515 Free article. Review.
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.
Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. Joh JE, et al. Among authors: laronga c. Oncologist. 2011;16(11):1520-6. doi: 10.1634/theoncologist.2011-0045. Epub 2011 Oct 20. Oncologist. 2011. PMID: 22016474 Free PMC article.
Indications for axillary ultrasound use in breast cancer patients.
Joh JE, Han G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Joh JE, et al. Among authors: laronga c. Clin Breast Cancer. 2012 Dec;12(6):433-7. doi: 10.1016/j.clbc.2012.09.009. Epub 2012 Oct 11. Clin Breast Cancer. 2012. PMID: 23062709
Menopausal status does not predict Oncotype DX recurrence score.
Carr DN, Vera N, Sun W, Lee MC, Hoover S, Fulp W, Acs G, Laronga C. Carr DN, et al. Among authors: laronga c. J Surg Res. 2015 Sep;198(1):27-33. doi: 10.1016/j.jss.2015.05.034. Epub 2015 Jun 12. J Surg Res. 2015. PMID: 26095420
159 results